Eli Lilly & Co. (LLY)
1173.92
-2.18
(-0.19%)
USD |
NYSE |
Aug 28, 16:00
1172.50
-1.42
(-0.12%)
After-Hours: 18:25
Eli Lilly Free Cash Flow : 13.56B for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.56B |
| March 31, 2026 | 10.37B |
| December 31, 2025 | 5.964B |
| September 30, 2025 | 6.436B |
| June 30, 2025 | -50.30M |
| March 31, 2025 | -1.270B |
| December 31, 2024 | 414.30M |
| September 30, 2024 | -2.275B |
| June 30, 2024 | -3.628B |
| March 31, 2024 | -3.896B |
| December 31, 2023 | -3.152B |
| September 30, 2023 | -164.90M |
| June 30, 2023 | 3.211B |
| March 31, 2023 | 3.786B |
| December 31, 2022 | 4.600B |
| September 30, 2022 | 5.339B |
| June 30, 2022 | 4.950B |
| March 31, 2022 | 5.824B |
| December 31, 2021 | 5.388B |
| September 30, 2021 | 4.621B |
| June 30, 2021 | 4.837B |
| March 31, 2021 | 5.565B |
| December 31, 2020 | 4.470B |
| September 30, 2020 | 5.112B |
| June 30, 2020 | 4.890B |
| Date | Value |
|---|---|
| March 31, 2020 | 3.684B |
| December 31, 2019 | 3.483B |
| September 30, 2019 | 2.671B |
| June 30, 2019 | 3.324B |
| March 31, 2019 | 2.217B |
| December 31, 2018 | 2.506B |
| September 30, 2018 | 2.931B |
| June 30, 2018 | 2.543B |
| March 31, 2018 | 4.313B |
| December 31, 2017 | 3.452B |
| September 30, 2017 | 3.854B |
| June 30, 2017 | 3.852B |
| March 31, 2017 | 3.579B |
| December 31, 2016 | 3.759B |
| September 30, 2016 | 2.357B |
| June 30, 2016 | 1.706B |
| March 31, 2016 | 1.139B |
| December 31, 2015 | 1.147B |
| September 30, 2015 | 1.787B |
| June 30, 2015 | 2.118B |
| March 31, 2015 | 2.282B |
| December 31, 2014 | 2.801B |
| September 30, 2014 | 3.092B |
| June 30, 2014 | 3.717B |
| March 31, 2014 | 4.466B |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Johnson & Johnson | 22.61B |
| Merck & Co., Inc. | 16.06B |
| Pfizer Inc. | 10.99B |
| Bristol Myers Squibb Co. | 11.44B |
| Atai Beckley, Inc. | -134.54M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 10.69B |
| Cash from Investing (Quarterly) | -15.40B |
| Cash from Financing (Quarterly) | 8.426B |
| Free Cash Flow Per Share (Quarterly) | 5.007 |
| Free Cash Flow to Equity (Quarterly) | -7.063B |
| Free Cash Flow to Firm (Quarterly) | 4.685B |
| Free Cash Flow Yield | 1.27% |